Literature DB >> 10588275

Cost-analysis of management strategies for children with vesico-ureteric reflux.

L Nicklasson1, S Högård.   

Abstract

This study is an economic evaluation of three treatment strategies for vesico-ureteric reflux in children: neo-implantation; subureteric injection; and antibacterial prophylaxis. Cost-analysis was used to compare the strategies, implying that the differences in benefits between them were not measured. Direct and indirect costs are included, taking the analytical viewpoint of the community. For the surgical strategies, data from four different hospitals in Sweden were used, and for the prophylactic strategy, data was gathered through a survey of 31 hospitals. The treatment strategies were ranked in the following order (bilateral reflux in parentheses): (i) subureteric injection SEK 25,000-28,000 (26,000-36,000); (ii) antibacterial prophylaxis SEK 16,000-36,000; and (iii) neo-implantation SEK 65,000-90,000 (72,000-95,000).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588275     DOI: 10.1111/j.1651-2227.1999.tb01322.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  6 in total

1.  Prediction of vesicoureteral reflux after a first febrile urinary tract infection in children: validation of a clinical decision rule.

Authors:  S Leroy; E Marc; C Adamsbaum; D Gendrel; G Bréart; M Chalumeau
Journal:  Arch Dis Child       Date:  2005-05-12       Impact factor: 3.791

2.  Clinical course of prenatally detected primary vesicoureteral reflux.

Authors:  José Maria Penido Silva; Eduardo Araujo Oliveira; José Silvério Santos Diniz; Maria Cândida Ferrarez Bouzada; Renata Moura Vergara; Barbara Caldeira Souza
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

3.  The demographics and costs of inpatient vesicoureteral reflux management in the USA.

Authors:  John David Spencer; Andrew Schwaderer; Kirk McHugh; Brian Vanderbrink; Brian Becknell; David S Hains
Journal:  Pediatr Nephrol       Date:  2011-05-10       Impact factor: 3.714

Review 4.  Vesicoureteric reflux and reflux nephropathy.

Authors:  Chulananda D A Goonasekera; Chandra K Abeysekera
Journal:  Indian J Pediatr       Date:  2003-03       Impact factor: 1.967

5.  Endoscopic injection therapy for treatment of vesicoureteric reflux: A 20-year perspective.

Authors:  Michael P Leonard
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253

6.  Endoscopic treatment of vesicoureteral reflux: Current status.

Authors:  Göran Läckgren
Journal:  Indian J Urol       Date:  2009-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.